Treatment of inflammatory skin disease
US9724409B2 · kind B2 · utility
1Cited by
0References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 4, 2012 |
| Grant date | Aug 8, 2017 |
| Priority date | — |
| Expiry date | Jun 23, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The number of acne lesions in a human subject is reduced by administering to the subject a pharmaceutical composition that includes a pharmaceutically acceptable carrier and a therapeutically effective amount of an agent that selectively binds IL-1α. Anxiety and other psychiatric conditions are also improved with this treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.